Africa Healthcare Industry Outlook, 2017
|発行||Frost & Sullivan||商品コード||356952|
|出版日||ページ情報||英文 49 Pages
|アフリカのヘルスケア産業の見通し Africa Healthcare Industry Outlook, 2017|
|出版日: 2017年11月30日||ページ情報: 英文 49 Pages||
Gearing Towards Universal Healthcare Coverage and Leveraging Partnerships to Improve Access to Services
In this research deliverable, Frost & Sullivan's analyst team provides bold perspectives and predictions for the African healthcare industry in 2017. The markets covered include pharmaceuticals and biotechnology, in-vitro diagnostics, medical devices, medical imaging and healthcare IT. The analysis captures the impact of trends that are expected to transpire over the upcoming year as organisations shift to prepare for the future. This study provides guidance on where to find the greatest opportunities for expansion. The continuous burden of disease on the continent and a dampened economic outlook will see the African healthcare industry focussing on more cost-effective products and services.
In addition, the regulatory environment will see a major transformation in each country. Areas exhibiting high growth opportunities will be the main focus of governments and industries alike. Business models specific to the African continent will be pursued in contrast to those in the larger markets of developed nations. The growth trends of emerging markets such as China, India and Brazil will play a key role in shaping the healthcare outlook of the African market. Major investments in key health sectors will be seen in 2017, with an important focus on digital transformation. Some of the expected areas of focus are advanced diagnostic tools, artificial intelligence and mHealth. Mergers and acquisitions are expected as stakeholders collaborate to achieve common outcomes. The outlook foresees increased collaboration and M&A activities between the life sciences and medical device industries, in which product designs will support prevention of the onset of chronic and degenerative diseases. The focus on communicable diseases such as HIV/AIDS and malaria will continue to be in the spotlight in 2017 for a majority of the nations. Health spending is expected to rise in the continent with governments aiming to meet millennium development goals.